Rare Disease Market Access and Orphan Drug Commercialization

Who Should Attend

Executives in market access and commercialization from pharmaceutical and biotech companies within divisions of rare, genetic, and orphan diseases will find this Summit of great value. 

In addition, leadership from the following roles will be in attendance:

• Market Access
• Commercialization/Commercial Development
• Pricing
• Reimbursement
• Regulatory
• Marketing
• Health Economics
• Outcomes Research
• Policy
• P&T Committees
• Medical Directors
• Business Development
• Orphan Foundations/Associations
• Product launch
• Contract Research Organizations
• Medical and Pharmacy Payers
• Advocacy Groups
• Academia